Enovis to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Enovis (NYSE: ENOV), a medical technology growth company, has announced its participation in three upcoming investor conferences:

• Canaccord Genuity 44th Annual Growth Conference on August 13th
• Wells Fargo Healthcare Conference on September 5th
• Baird 2024 Global Healthcare Conference on September 11th

The company's management team, including CFO Ben Berry and CEO Matt Trerotola, will participate in fireside chats at these events. Live audio webcasts and replays will be available on Enovis' website under the Investors tab. Enovis is dedicated to developing clinically differentiated solutions for better patient outcomes and improved workflows in orthopedics and beyond.

News Market Reaction – ENOV

+2.05%

1 alert

+2.05% News Effect

On the day this news was published, ENOV gained 2.05%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

• Canaccord Genuity 44th Annual Growth Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, August 13th at 2:00 p.m. Eastern Time.
• Wells Fargo Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Thursday, September 5th at 11:00 a.m. Eastern Time.
• Baird 2024 Global Healthcare Conference: Matt Trerotola, Chair, and Chief Executive Officer, will participate in a fireside chat on Wednesday, September 11th at 12:50 p.m. Eastern Time.

A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.

Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
+1-917-734-7450
investorrelations@enovis.com

FAQ

When is Enovis (ENOV) participating in the Canaccord Genuity 44th Annual Growth Conference?

Enovis (ENOV) is participating in the Canaccord Genuity 44th Annual Growth Conference on Tuesday, August 13th at 2:00 p.m. Eastern Time.

Who will represent Enovis (ENOV) at the Wells Fargo Healthcare Conference?

Ben Berry, Chief Financial Officer of Enovis (ENOV), will represent the company at the Wells Fargo Healthcare Conference on September 5th.

What time is Enovis (ENOV) scheduled for the Baird 2024 Global Healthcare Conference?

Enovis (ENOV) is scheduled for a fireside chat at the Baird 2024 Global Healthcare Conference on Wednesday, September 11th at 12:50 p.m. Eastern Time.

How can investors access the webcasts of Enovis (ENOV) conference presentations?

Investors can access live audio webcasts and replays of Enovis (ENOV) conference presentations on the company's website under the Investors tab at Events and Presentations.

What is the stock symbol for Enovis ?

The stock symbol for Enovis is ENOV, listed on the New York Stock Exchange (NYSE).